BiotechTube
Prosomnus

Prosomnus

OSA
Pleasanton, United States· Est.
prosomnus.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $50M

Overview

Prosomnus is a public medical device company (NASDAQ: OSA) focused on disrupting the sleep apnea treatment market with its precision-engineered oral appliances. Founded in 2013, the company has established a significant presence, claiming hundreds of thousands of users worldwide, by addressing the critical adherence problem of traditional CPAP therapy. Its strategy hinges on a hybrid commercial model engaging both dental and medical sleep providers, supported by clinical data demonstrating strong patient preference (96% over CPAP) and a compelling economic value proposition to payers.

Obstructive Sleep Apnea (OSA)Snoring

Technology Platform

Proprietary platform utilizing artificial intelligence-assisted design and robotic manufacturing to create precision-calibrated oral appliances for sleep apnea.

Funding History

3
Total raised:$50M
IPO$15M
Series B$23M
Series A$12M

Opportunities

The massive, under-diagnosed OSA population and poor CPAP adherence create a multi-billion dollar addressable market for effective alternatives.
Prosomnus's precision technology and hybrid commercial model position it to capture significant share in the fast-growing Oral Appliance Therapy segment, supported by a compelling economic value proposition to payers.

Risk Factors

Key risks include dependence on favorable and stable insurance reimbursement, execution challenges in scaling its provider network, intense competition from CPAP giants and other OAT players, and the financial sustainability of its growth plans as a public company.

Competitive Landscape

Prosomnus primarily competes against CPAP (ResMed, Philips) on adherence and comfort, and against other oral appliance makers (e.g., SomnoMed) on technological precision and clinical outcomes. Its AI-driven design and robotic manufacturing provide a key point of differentiation in the OAT market.

More companies in Digital Health & Biotech SaaS →More companies in United States →